Even mildly reduced kidney function (manifesting as micro-albuminuria) is an established risk factor for progression to renal disease and cardiovascular events (56, 57), thereby linking elevated circulating SAA levels with early stage renal dysfunction and pre-clinical atherosclerosis. The gene discussed is SAA2; the disease is kidney disorder.